MedPath

To compare respiratory muscle strength recovery using ultrasound after neuromuscular reversal with Neostigmine versus Sugammadex.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/061766
Lead Sponsor
Maulana Azad Medical College and associated Lok Nayak Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients 18 to 65 years of age

2.Patients having ASA physical status I and II

3.BMI < 30 Kg/m2

Exclusion Criteria

1.Pregnant or breastfeeding women

2.Patient with history of allergy to Sugammadex, Neostigmine or Vecuronium

3.Patient with renal or hepatic impairment

4.Patient with known neuromuscular disease

5.Suspected difficult airway

6.Patients in whom satisfactory ultrasound imaging or space for placement of the ultrasonic probe will be difficult

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Mean change in TFIO from baseline to 5 minutes post extubationTimepoint: At the time of induction & 5 minutes & 30 minutes after extubation
Secondary Outcome Measures
NameTimeMethod
1. Mean change in thickness fraction of internal oblique from baseline to 30 minutes post extubation. <br/ ><br>2. Mean change in diaphragmatic thickness fraction from baseline to 5 and 30 minutes post extubation <br/ ><br>3. Mean time to train of four ratio recovery to 0.9Timepoint: From baseline to 30 minutes and from baseline to 5 and 30 minutes post extubation.
© Copyright 2025. All Rights Reserved by MedPath